Johanson K, Appelbaum E, Doyle M, Hensley P, Zhao B, Abdel-Meguid S S, Young P, Cook R, Carr S, Matico R
Department of Protein Biochemistry, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
J Biol Chem. 1995 Apr 21;270(16):9459-71. doi: 10.1074/jbc.270.16.9459.
Human interleukin 5 (hIL5) and soluble forms of its receptor alpha subunit were expressed in Drosophila cells and purified to homogeneity, allowing a detailed structural and functional analysis. B cell proliferation confirmed that the hIL5 was biologically active. Deglycosylated hIL5 remained active, while similarly deglycosylated receptor alpha subunit lost activity. The crystal structure of the deglycosylated hIL5 was determined to 2.6-A resolution and found to be similar to that of the protein produced in Escherichia coli. Human IL5 was shown by analytical ultracentrifugation to form a 1:1 complex with the soluble domain of the hIL5 receptor alpha subunit (shIL5R alpha). Additionally, the relative abundance of ligand and receptor in the hIL5.shIL5R alpha complex was determined to be 1:1 by both titration calorimetry and SDS-polyacrylamide gel electrophoresis analysis of dissolved cocrystals of the complex. Titration microcalorimetry yielded equilibrium dissociation constants of 3.1 and 2.0 nM, respectively, for the binding of hIL5 to shIL5R alpha and to a chimeric form of the receptor containing shIL5R alpha fused to the immunoglobulin Fc domain (shIL5R alpha-Fc). Analysis of the binding thermodynamics of IL5 and its soluble receptor indicates that conformational changes are coupled to the binding reaction. Kinetic analysis using surface plasmon resonance yielded data consistent with the Kd values from calorimetry and also with the possibility of conformational isomerization in the interaction of hIL5 with the receptor alpha subunit. Using a radioligand binding assay, the affinity of hIL5 with full-length hIL5R alpha in Drosophila membranes was found to be 6 nM, in accord with the affinities measured for the soluble receptor forms. Hence, most of the binding energy of the alpha receptor is supplied by the soluble domain. Taken with other aspects of hIL5 structure and biological activity, the data obtained allow a prediction for how 1:1 stoichiometry and conformational change can lead to the formation of hIL5.receptor alpha beta complex and signal transduction.
人白细胞介素5(hIL5)及其受体α亚基的可溶性形式在果蝇细胞中表达并纯化至同质,从而能够进行详细的结构和功能分析。B细胞增殖证实hIL5具有生物活性。去糖基化的hIL5仍保持活性,而同样去糖基化的受体α亚基则失去活性。去糖基化hIL5的晶体结构分辨率达到2.6埃,发现与大肠杆菌中产生的蛋白质结构相似。分析超速离心表明人白细胞介素5与hIL5受体α亚基的可溶性结构域(shIL5Rα)形成1:1复合物。此外,通过滴定热分析法和该复合物溶解共晶体的SDS聚丙烯酰胺凝胶电泳分析,确定hIL5.shIL5Rα复合物中配体与受体的相对丰度为1:1。滴定微量热法得出hIL5与shIL5Rα以及与包含与免疫球蛋白Fc结构域融合的shIL5Rα的嵌合受体形式(shIL5Rα-Fc)结合的平衡解离常数分别为3.1和2.0 nM。对IL5及其可溶性受体结合热力学的分析表明,构象变化与结合反应相关。使用表面等离子体共振进行的动力学分析得出的数据与量热法测得的Kd值一致,也与hIL5与受体α亚基相互作用中构象异构化的可能性相符。使用放射性配体结合测定法,发现hIL5与果蝇膜中全长hIL5Rα的亲和力为6 nM,这与可溶性受体形式测得的亲和力一致。因此,α受体的大部分结合能由可溶性结构域提供。结合hIL5结构和生物活性的其他方面,所得数据能够预测1:1化学计量比和构象变化如何导致hIL5.受体αβ复合物的形成和信号转导。